Investigation of a Side-polished Fiber MZI and Its Sensing Performance

A novel all-fiber Mach–Zehnder interferometer (MZI), which consists of lateral core fusion splicing of a short section of side-polished single mode fiber (SMF) between two SMFs was proposed and demonstrated. A simple fiber side-polished platform was built to control the side polished depth through a microscope. The sensitivity of the fiber MZI structure to the surrounding refractive index (RI) can be greatly improved with the increase of the side-polished depth, but has no effect on the temperature sensitivity. The sensor with a polished depth of 44.2 μm measured RI sensitivity up to -118.0 nm/RIU (RI unit) in the RI range from 1.333 to 1.387, which agrees well with simulation results by using the beam propagation method (BPM). In addition, the fiber MZI structure also can achieve simultaneous measurement of both RI and temperature. These results show its potential for use in-line fiber type sensing application

Room-temperature antiferromagnetic CrSe monolayer with tunable metal-insulator transition in ferroelectric heterostructures

Recently, there has been a rapidly growing interest in two-dimensional (2D) transition metal chalcogenide monolayers (MLs) due to their unique magnetic and electronic properties. By using an evolutionary algorithm and first-principles calculations, we report the discovery of a previously unexplored, chemically, energetically, and thermodynamically stable 2D antiferromagnetic (AFM) CrSe ML with a N\'eel temperature higher than room temperature. Remarkably, we predict an electric field-controllable metal-insulator transition (MIT) in a van der Waals (vdW) heterostructure comprised of CrSe ML and ferroelectric Sc2CO2. This tunable transition in CrSe/Sc2CO2 heterostructure is attributed to the change in the band alignment between CrSe and Sc2CO2 caused by the ferroelectric polarization reversal in Sc2CO2. Our findings suggest that 2D AFM CrSe ML has important potential applications in AFM spintronics, particularly in the gate voltage conducting channel.Comment: 13 Pages, 4 Figure

Clinical efficacy and safety of edaravone therapy in acute cerebral haemorrhage

Purpose: To evaluate the clinical efficacy and safety of edaravone in the treatment of acute cerebral haemorrhage (ACH).Methods: This study recruited 120 patients who developed ACH. The patients were divided into control and treatment groups with 60 patients per group. The control group underwent conventional treatment and the treatment group also received intravenous edaravone. The volumes of cerebral edema and cerebral hematoma, high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) levels, and Chinese Stroke Scale (CSS) score before and after treatment were compared between the two groups.Results: The respective cerebral edema volumes of the control and treatment groups decreased from 20.99 ± 12.09 and 21.80 ± 12.01 mL on day 0 to 11.23 ± 6.34 and 12.11 ± 5.98 mL at day 7 and 4.69 ± 4.03 and 4.64 ± 3.9 mL on day 14 (P < 0.05). The respective cerebral hematoma volumes of the control and treatment groups decreased from 18.98 ± 12.04 and 18.97 ± 12.07 mL on day 0 to 12.34 ± 6.57 and 11.89 ± 4.01 mL at day 7 and 9.49 ± 3.95 and 9.52 ± 3.96 mL on day 14. Compared with pretreatment, hs-CRP and IL-6 levels and CSS score of the two groups decreased significantly following treatment (p < 0.05); the differences in the cerebral edema and hematoma volumes of the two groups on days 7 and 14 were not significant (p > 0.05). The hs-CRP and IL-6 levels and CSS scores of the treatment group decreased appreciably (p < 0.05), while the incidence of adverse reactions in the treatment and control groups was 16.67 and 13.33 %, respectively, but the difference was not significant (p > 0.05).Conclusion: Edaravone shows remarkable clinical efficacy and safety with no obvious adverse reactions in the treatment of ACH. Therefore, its use is recommended.Keywords: Cerebral haemorrhage, Edaravone, Cerebral edema, C-reactive protein, Interleukin-6, Chinese Stroke Scal

Secret color images sharing schemes based on XOR operation

This paper presents two new constructions for the secret color images sharing schemes .One is a (n, n) threshold scheme, which can be constructed based on XOR operation. The other is a (2, n) threshold scheme, which can be constructed by using AND and XOR operations. The two schemes have no pixel expansion, and the time complexity for constructing shared images is O(k1n), excluding the time needed for generating n distinct random matrices (here k1 is the size of the shared image). The reconstructed images can be obtained in the two schemes by using the XOR operation alone. The relative differences of the two schemes are 1 and 1/2, respectively. The time complexity of the recovered images is O(k1n) and O(2k1), respectively. The two schemes also provide perfect secrecy

Decreased NPC1L1 expression in the liver from Chinese female gallstone patients

<p>Abstract</p> <p>Background</p> <p>Cholesterol gallstone disease is a very common disease in both industrialized and developing countries. Many studies have found that cholesterol gallstones are more common in women than men. The molecular mechanisms underlying the relationship between female gallstone disease and hepatic sterol transporters are still undergoing definition and have not been evaluated in humans.</p> <p>Aims</p> <p>The aim of this study is to probe for underlying hepatic molecular defects associated with development of gallstones in female.</p> <p>Methods/Results</p> <p>Fifty-seven nonobese, normolipidemic Chinese female gallstone patients (GS) were investigated with 12 age- and body mass index-matched female gallstone-free controls (GSF). The bile from the female GS had higher cholesterol saturation than that from the female GSF. The hepatic NPC1L1 mRNA levels were lower in female GS, correlated with SREBP2 mRNA. NPC1L1 downregulation was confirmed at protein levels. Consistently, immunohistochemistry showed decreased NPC1L1 expression in female GS.</p> <p>Conclusions</p> <p>The decreased hepatic NPC1L1 levels in female GS might indicate a downregulated reabsorption of biliary cholesterol in the liver, which, in turn, leads to the cholesterol supersaturation of bile. Our data are consistent with the possibility that hepatic NPC1L1 may be mediated by SREBP2.</p

Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis

BACKGROUND: Intravascular ultrasound (IVUS) can be a useful tool during drug-eluting stents (DES) implantation as it allows accurate assessment of lesion severity and optimal treatment planning. However, numerous reports have shown that IVUS guided percutaneous coronary intervention is not associated with improved clinical outcomes, especially in non-complex patients and lesions. METHODS: We searched the literature in Medline, the Cochrane Library, and other internet sources to identify studies that compare clinical outcomes between IVUS-guided and angiography-guided DES implantation. Random-effects model was used to assess treatment effect. RESULTS: Twenty eligible studies with a total of 29,068 patients were included in this meta-analysis. The use of IVUS was associated with significant reductions in major adverse cardiovascular events (MACE, odds ratios [OR] 0.77, 95 % confidence intervals [CI] 0.71-0.83, P < 0.001), death (OR 0.62, 95 % CI 0.54-0.71, p < 0.001), and stent thrombosis (OR 0.59, 95 % CI: 0.47-0.73, P < 0.001). The benefit was also seen in the repeated analysis of matched and randomized studies. In stratified analysis, IVUS guidance appeared to be beneficial not only in patients with complex lesions or acute coronary syndromes (ACS) but also patients with mixed lesions or presentations (MACE: OR 0.69, 95 % CI: 0.60-0.79, p < 0.001, OR 0.81, 95 % CI 0.74-0.90, p < 0.001, respectively). By employing meta-regression analysis, the benefit of IVUS is significantly pronounced in patients with complex lesions or ACS with respect to death (p = 0.048). CONCLUSIONS: IVUS guidance was associated with improved clinical outcomes, especially in patients with complex lesions admitted with ACS. Large, randomized clinical trials are warranted to identify populations and lesion characteristics where IVUS guidance would be associated with better outcomes

Synthesis of Pt nanoparticles on electrochemically reduced graphene oxide by potentiostatic and alternate current methods

Reduced graphene oxide (RGO) has been synthesized on Pt wires by means of a potentiodynamic method between +0.6 V and -1.4'V for 20 scans. Cyclic voltammetry characterization of the coatings showed the typical capacitative behavior of graphene. Pt nanoparticles were synthesized on Pt-RGO electrodes by means of potentiostatic methods and a comparison between different synthesis potentials (-0.16, 0, +0.2 and +0.4 V) for the same synthesis charge (mC.cm(-2)) was established. The electrodes obtained were characterized in 0.5 M H2SO4 solution to observe the characteristic oxidation and reduction processes of the Pt surface. A 0.5 M H2SO4/0.5 M CH3OH solution was used to measure the catalytic properties of the deposits against methanol oxidation. The most appropriate potential to perform the synthesis was 0 V followed by -0.16 V and +0.2 V. The morphology of the coatings varied depending on the potential applied as observed by scanning electron microscopy. Alternate current methods were also used to synthesize Pt nanoparticles and compare the results with the traditional potentiostatic method. Different frequencies were used: 0.1, 1, 10, 100, 1000 and 10000 Hz. Alternate current synthesis is more efficient than traditional potentiostatic methods, obtaining more electroactive coatings with less effective synthesis time. (C) 2014 Elsevier Inc. All rights reserved.Authors wish to thank to the Spanish Ministerio de Ciencia e Innovacion (contract CTM2011-23583) and Universitat Politecnica de Valencia (Vicerrectorado de Investigacion PAID-06-10 contract 003-233) for the financial support. J. Molina is grateful to the Conselleria d'Educacio, Formacio i Ocupacio (Generalitat Valenciana) for the Programa VALi+D Postdoctoral Fellowship. A.I. del Rio is grateful to the Spanish Ministerio de Ciencia y Tecnologia for the FPI fellowship.Molina Puerto, J.; Fernández Sáez, J.; Del Río García, AI.; Bonastre Cano, JA.; Cases Iborra, FJ. (2014). Synthesis of Pt nanoparticles on electrochemically reduced graphene oxide by potentiostatic and alternate current methods. Materials Characterization. 89:56-68. https://doi.org/10.1016/j.matchar.2014.01.003S56688

SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras

SHANK3, a synaptic scaffold protein and actin regulator, is widely expressed outside of the central nervous system with predominantly unknown function. Solving the structure of the SHANK3 N-terminal region revealed that the SPN domain is an unexpected Ras-association domain with high affinity for GTP-bound Ras and Rap G-proteins. The role of Rap1 in integrin activation is well established but the mechanisms to antagonize it remain largely unknown. Here, we show that SHANK1 and SHANK3 act as integrin activation inhibitors by sequestering active Rap1 and R-Ras via the SPN domain and thus limiting their bioavailability at the plasma membrane. Consistently, SHANK3 silencing triggers increased plasma membrane Rap1 activity, cell spreading, migration and invasion. Autism-related mutations within the SHANK3 SPN domain (R12C and L68P) disrupt G-protein interaction and fail to counteract integrin activation along the Rap1-RIAM-talin axis in cancer cells and neurons. Altogether, we establish SHANKs as critical regulators of G-protein signalling and integrin-dependent processes